Weight-Loss Revolution Enters the World of Childhood
Recent years have seen a massive leap in the use of modern weight-loss drugs, specifically GLP-1 receptor agonist medications such as Wegovy and Mounjaro, which have transformed from mere treatments for type 2 diabetes into widespread, magical tools for adult weight loss. However, this is not limited to adults alone; recent data has revealed that hundreds of children in England, including youngsters under the age of 12, have received official prescriptions to take these injections.
Medical Risks and a Critical Biological Model
The expansion in administering these drugs to children raises serious health concerns among physicians and endocrinologists. The bodies of children and adolescents are still in a complex and delicate stage of biological development, and interfering with metabolic pathways and fat-burning through powerful drugs may leave adverse effects on bones, muscle mass, and general hormonal development. Furthermore, data on the long-term effects of these medications on young age groups remains extremely sparse, leaving youngsters looking rather like living test subjects.
The Urgent Need for Oversight and Specialization
Experts emphasize that tackling childhood obesity should not be through quick pharmaceutical solutions alone, but requires an integrated treatment system that includes precise medical supervision from specialists in pediatric nutrition and behavior. Excessive reliance on injections without a fundamental shift in dietary patterns and physical activity may create a generation that depends entirely on chemical drugs to maintain its weight, while ignoring the psychological and social aspects associated with food and public health.
By: Hany Sallam
Source: theguardian.com


Latest video
تابع معنا تحليل قراءة الصحف اليومية مع الكاتب الصحفي Hany Sallam عبر